MAUDE Adverse Event Report: CORIN LTD BIOLOX DELTA; TRINITY ACETABULAR HIP SYSTEM WITH HXLPE LINERS (BIOLOX DELTA FEMORAL HEADS)

Model Number	104.3605
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code	Joint Dislocation (2374)
Date of Event	03/02/2026
Type of Reportable Event	Serious Injury
Event or Problem Description
Trinity revision (with ops used in primary surgery) of the ecima liner and biolox delta ceramic head after approximately 1 year due to dislocation.
Additional Manufacturer Narrative
Per comp - (b)(4) initial report.Additional information, including post primary and pre revision x-rays, operative notes (primary and revision), patient activity level, weight and medical history, whether the patient followed correct post-op protocol, whether the patient experienced any slips / falls or other trauma post primary surgery, what was implanted at the revision and an update on the patient post revision was requested in order to progress with the investigation of this event.The reporter has confirmed that this information cannot be provided and thus the scope of the investigation is limited.The appropriate device details have been provided and the relevant device manufacturing records will be identified and reviewed.Please note: this report is filed with the fda due to an adverse event experienced with a device that is similar to those placed on the market in the usa, however, this event occurred outside of the usa.The submission of this report does not constitute an admission that the device, reporting entity, entity's representative or distributor caused or contributed to this event.
Event or Problem Description
Trinity revision (with ops used in primary surgery) of the ecima liner and biolox delta ceramic head after approximately 1 year due to dislocation.
Additional Manufacturer Narrative
Per (b)(4) final report.Additional information, including post primary and pre revision x-rays, operative notes (primary and revision), patient activity level, weight and medical history, whether the patient followed correct post-op protocol, whether the patient experienced any slips / falls or other trauma post primary surgery, what was implanted at the revision and an update on the patient post revision was requested in order to progress with the investigation of this event.The reporter has confirmed that this information cannot be provided and thus the scope of the investigation is limited.The appropriate device details were provided and the relevant device manufacturing records have been identified and reviewed.All parts associated with these records conformed to material and dimensional specifictaion at the time of manufacture.A review of product history records was performed which revealed that no anomalies were observed in the device history records of ops insight, ops acetabular and ops femoral guide, which may have caused or contributed to this event.The ops insight plan was made in accordance with specification.There is no indication that ops would have contributed to this event.Based on the available information, no further investigation can be conducted and the root cause of the reported dislocation could not be determined.This case is now considered closed, however, should any additional information become available then this case can be re-opened for further investigation.Please note: this report is filed with the fda due to an adverse event experienced with a device that is similar to those placed on the market in the usa, however, this event occurred outside of the usa.The submission of this report does not constitute an admission that the device, reporting entity, entity's representative or distributor caused or contributed to this event.

• Brand Name: BIOLOX DELTA
• Common Device Name: TRINITY ACETABULAR HIP SYSTEM WITH HXLPE LINERS (BIOLOX DELTA FEMORAL HEADS)
• Manufacturer (Section D): CORIN LTD; the corinium centre; cirencester, gloucestershire GL7 1 YJ; UK GL7 1YJ
• Manufacturer (Section G): CORIN LTD; the corinium centre; cirencester, gloucestershire GL7 1 YJ; UK GL7 1YJ
• Manufacturer Contact: franck didier ; the corinium centre; cirencester, gloucestershire GL7 1-YJ ; UK GL7 1YJ
• MDR Report Key: 24726008
• Report Number: 9614209-2026-00042
• Device Sequence Number: 13328450
• Product Code: LZO
• Combination Product (Y/N): N
• Initial Reporter Country: AS
• PMA/510(K) Number: K110087
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2025
• Device Explanted Year: 2026
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Company Representative
• Initial Reporter Occupation: Non-Healthcare Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 05/21/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Model Number: 104.3605
• Device Catalogue Number: NOT APPLICABLE
• Device Lot Number: 577584
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Was the Report Sent to FDA?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 03/02/2026
• Supplement Date Received by Manufacturer: 03/02/2026
• Initial Report FDA Received Date: 03/30/2026
• Supplement Report FDA Received Date: 05/21/2026
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 11/07/2024
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: OPS ACETABULAR GUIDE: 1248-0500, JSD_OE_46087; OPS ACETABULAR GUIDE: 1248-0500, JSD_OE_46087.; OPS FEMORAL GUIDE: 1250-0100, JSD_OE_46087; OPS FEMORAL GUIDE: 1250-0100, JSD_OE_46087.; OPS INSIGHT: 1200-0000, JSD_OE_46087; OPS INSIGHT: 1200-0000, JSD_OE_46087.; TRINITY ECIMA LINER: 322.03.936, 584890; TRINITY ECIMA LINER: 322.03.936, 584890.
• Outcome Attributed to Adverse Event: Required Intervention; Hospitalization
• Patient Age: 75 YR
• Patient Sex: Female